Quick recap of why this matters on semaglutide Semaglutide, available in India as Obeda (Dr Reddys Laboratories, launched March 2026) and as Ozempic, is a GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives significant weight loss
Here are some immediate steps you can take: Stop Using Semaglutide Temporarily: If the rash is severe or rapidly spreading, stop using semaglutide until you can consult your healthcare provider
Is Semaglutide approved in Canada
psychiatric and oncological conditions, are complex and affect multiple body systems, including the nervous, endocrine, immune, cardiovascular and digestive systems, among others
This study demonstrated that patients with overweight or obesity who were treated with semaglutide and enrolled in the WeGoTogether program had meaningful long-term (24 months) weight loss
Bottom line is, managing night sweats isnt just about comfort, its about your overall health and happiness